Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Recruiting 6Active not recruiting 6Completed 4Withdrawn 2Unknown 2Terminated 2Not yet recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2Breast 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Genitourinary 1CNS 1

Conditions

Breast Neoplasms 2Prostatic Neoplasms 1Lung Neoplasms 1Inflammatory Breast Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Trastuzumab 26Carboplatin 20pertuzumab 19Paclitaxel 19Cyclophosphamide 18pyrotinib 17Docetaxel 16Capecitabine 16Letrozole 14trastuzumab deruxtecan 13Radiotherapy 13Drug Therapy 13Standard of Care 11Fulvestrant 11dalpiciclib 10Specimen Handling 10Anastrozole 10pembrolizumab 9exemestane 9Epirubicin 9sacituzumab govitecan 8palbociclib 8eribulin 8abemaciclib 7Magnetic Resonance Spectroscopy 7Doxorubicin 7130-nm albumin-bound paclitaxel 7toripalimab 6Tamoxifen 6Neoadjuvant Therapy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × X-Rays × Breast × Clear all
NCT06982222 2026-05-13

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

National Cancer Institute (NCI)

Phase 1 Not yet recruiting
24 enrolled
BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms

NCT07474090 2026-03-16

STEPS-BC

Wake Forest University Health Sciences

Phase NA Not yet recruiting
120 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡